Gregory J. Downey's most recent trade in Lexaria Bioscience Corp was a trade of 121 common shares done at an average price of $2.1 . Disclosure was reported to the exchange on Oct. 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 14 Oct 2022 | 121 | 1,954 | - | 2.1 | 253 | common shares |
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 11,000 | 46,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 10,000 | 35,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 8,000 | 25,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 May 2021 | 8,000 | 17,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Gregory J. Downey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 5,000 | 25,000 | - | - | Stock Options |